Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell Cancer
Clinical trial NCT00059813 · COMPLETED
Trial details
- NCT number
- NCT00059813
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Primary completion
- 2005-06-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.